4//SEC Filing
Chevallard Daniel R. 4
Accession 0001815776-25-000072
CIK 0001815776other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 7:42 PM ET
Size
6.1 KB
Accession
0001815776-25-000072
Insider Transaction Report
Form 4
Chevallard Daniel R.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-11-07$22.71/sh+20$454→ 3,208 total - Purchase
Common Stock
2025-11-07$22.76/sh+2,178$49,563→ 5,386 total
Documents
Issuer
LENZ Therapeutics, Inc.
CIK 0001815776
Entity typeother
Related Parties
1- filerCIK 0001706176
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 7:42 PM ET
- Size
- 6.1 KB